Jointown Pharmaceutical Group Co., Ltd (600998.SS)
CNY 5.41
(-0.18%)
CNY 5.41
(-0.18%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 5.08 Billion CNY | -6.21% |
| 2022 | 4.71 Billion CNY | 24.05% |
| 2021 | 5.16 Billion CNY | -13.42% |
| 2020 | 5.92 Billion CNY | 15.07% |
| 2019 | 4.05 Billion CNY | 29.52% |
| 2018 | 3.12 Billion CNY | 22.19% |
| 2017 | 2.6 Billion CNY | 21.36% |
| 2016 | 2.06 Billion CNY | 20.87% |
| 2015 | 1.74 Billion CNY | 30.79% |
| 2014 | 1.35 Billion CNY | 18.34% |
| 2013 | 1.14 Billion CNY | 15.74% |
| 2012 | 984.52 Million CNY | 25.55% |
| 2011 | 781.03 Million CNY | 12.49% |
| 2010 | 707.12 Million CNY | 31.92% |
| 2009 | 469.33 Million CNY | 29.6% |
| 2008 | 404.45 Million CNY | 34.58% |
| 2007 | 301.88 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 1.46 Billion CNY | 55.6% |
| 2024 Q3 | 957.96 Million CNY | -37.01% |
| 2024 Q1 | 1.16 Billion CNY | -10.54% |
| 2023 Q1 | 1.28 Billion CNY | 48.73% |
| 2023 Q3 | 963.2 Million CNY | -36.89% |
| 2023 FY | - CNY | -6.21% |
| 2023 Q4 | 1 Billion CNY | 3.9% |
| 2023 Q2 | 1.52 Billion CNY | 18.89% |
| 2022 Q3 | 1.05 Billion CNY | -21.76% |
| 2022 FY | - CNY | 24.05% |
| 2022 Q4 | 863.08 Million CNY | -17.94% |
| 2022 Q1 | 1.09 Billion CNY | 104.08% |
| 2022 Q2 | 1.34 Billion CNY | 22.25% |
| 2021 Q3 | 826.55 Million CNY | -16.52% |
| 2021 Q4 | 538.86 Million CNY | -34.81% |
| 2021 FY | - CNY | -13.42% |
| 2021 Q1 | 1.09 Billion CNY | 6.53% |
| 2021 Q2 | 990.15 Million CNY | -9.57% |
| 2020 Q3 | 908 Million CNY | -34.77% |
| 2020 Q2 | 1.39 Billion CNY | 55.53% |
| 2020 Q1 | 895.01 Million CNY | -27.66% |
| 2020 Q4 | 1.02 Billion CNY | 13.2% |
| 2020 FY | - CNY | 15.07% |
| 2019 Q1 | 727.86 Million CNY | -28.65% |
| 2019 Q2 | 937.24 Million CNY | 28.77% |
| 2019 FY | - CNY | 29.52% |
| 2019 Q3 | 723.2 Million CNY | -22.84% |
| 2019 Q4 | 1.23 Billion CNY | 71.07% |
| 2018 Q2 | 584.12 Million CNY | -0.54% |
| 2018 FY | - CNY | 22.19% |
| 2018 Q4 | 1.02 Billion CNY | 73.13% |
| 2018 Q1 | 587.3 Million CNY | 0.59% |
| 2018 Q3 | 589.25 Million CNY | 0.88% |
| 2017 Q2 | 997.78 Million CNY | 65.35% |
| 2017 FY | - CNY | 21.36% |
| 2017 Q4 | 583.84 Million CNY | 28.05% |
| 2017 Q3 | 455.94 Million CNY | -54.3% |
| 2017 Q1 | 603.44 Million CNY | -11.21% |
| 2016 Q4 | 679.6 Million CNY | 99.34% |
| 2016 FY | - CNY | 20.87% |
| 2016 Q1 | 409.77 Million CNY | -27.42% |
| 2016 Q2 | 408.84 Million CNY | -0.23% |
| 2016 Q3 | 340.92 Million CNY | -16.61% |
| 2015 FY | - CNY | 30.79% |
| 2015 Q4 | 564.57 Million CNY | 104.3% |
| 2015 Q3 | 276.34 Million CNY | -21.71% |
| 2015 Q2 | 352.99 Million CNY | 5.82% |
| 2015 Q1 | 333.56 Million CNY | -21.78% |
| 2014 Q3 | 281.04 Million CNY | 10.26% |
| 2014 Q2 | 254.89 Million CNY | -0.67% |
| 2014 Q1 | 256.62 Million CNY | -41.2% |
| 2014 FY | - CNY | 18.34% |
| 2014 Q4 | 426.42 Million CNY | 51.73% |
| 2013 FY | - CNY | 15.74% |
| 2013 Q1 | 208.13 Million CNY | -47.52% |
| 2013 Q4 | 436.4 Million CNY | 155.75% |
| 2013 Q2 | 211.2 Million CNY | 1.48% |
| 2013 Q3 | 170.63 Million CNY | -19.21% |
| 2012 FY | - CNY | 25.55% |
| 2012 Q4 | 396.58 Million CNY | 218.4% |
| 2012 Q3 | 124.55 Million CNY | -27.31% |
| 2012 Q1 | 188.21 Million CNY | -42.19% |
| 2012 Q2 | 171.36 Million CNY | -8.96% |
| 2011 Q1 | 136.27 Million CNY | -53.08% |
| 2011 Q3 | 110.7 Million CNY | -10.47% |
| 2011 FY | - CNY | 12.49% |
| 2011 Q2 | 123.64 Million CNY | -9.27% |
| 2011 Q4 | 325.55 Million CNY | 194.07% |
| 2010 Q1 | 113.14 Million CNY | 0.0% |
| 2010 Q3 | 91.17 Million CNY | -27.32% |
| 2010 Q4 | 290.41 Million CNY | 218.52% |
| 2010 FY | - CNY | 31.92% |
| 2010 Q2 | 125.44 Million CNY | 10.87% |
| 2009 FY | - CNY | 29.6% |
| 2008 FY | - CNY | 34.58% |
| 2007 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Shanghai No.1 Pharmacy Co., Ltd. | 186.51 Million CNY | -2625.538% |
| LBX Pharmacy Chain Joint Stock Company | 3.06 Billion CNY | -65.615% |
| Yifeng Pharmacy Chain Co., Ltd. | 4.04 Billion CNY | -25.562% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 1.53 Billion CNY | -230.316% |